News & Press Releases

Mintz has been recognized by US News & World Report as a 2026 Best Company to Work For among US law firms, marking the third consecutive year the firm has earned this distinction.

Sige Gutman, Chair of Mintz’s Life Sciences Litigation Practice, was quoted in an Endpoints News article examining Supreme Court oral arguments on the limits of “skinny label” drug marketing and potential patent infringement liability for generic manufacturers.

Michelle Capezza offered commentary in an article with Fiduciary News about potential fiduciary risks tied to payroll and implementation errors under the Roth catch-up contribution mandate.

Mintz advised the placement agents in the $145 million private placement of First Tracks Biotherapeutics’ common stock, which included $80 million of common stock sold by First Tracks Biotherapeutics and $65 million of common stock sold by a selling stockholder. The private placement was in connection with the spin-off of First Tracks Biotherapeutics from AnaptysBio.

Member Theresa Carnegie was quoted in a Corporate Counsel article analyzing the broader impact of a recent pharmacy benefit manager (PBM) settlement and how it may affect health plans going forward.

Daniel Cody was quoted in a Healthcare Brew article advising physicians on how to assess whether a telemedicine company is operating legitimately before entering into a working relationship.